Filing Details

Accession Number:
0001104659-11-065233
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-18 18:54:36
Reporting Period:
2011-11-16
Filing Date:
2011-11-18
Accepted Time:
2011-11-18 18:54:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1126234 Newlink Genetics Corp NLNK Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1512133 J. David Lundquist C/O Newlink Genetics Corporation
2503 South Loop Dr., Suite 5100
Ames IA 50010
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-11-16 13,267 $0.00 24,642 No 4 C Indirect By David J. Lundquist Revocable Trust
Common Stock Acquisiton 2011-11-16 9,523 $0.00 34,165 No 4 C Indirect By David J. Lundquist Revocable Trust
Common Stock Acquisiton 2011-11-16 10,856 $0.00 45,021 No 4 C Indirect By David J. Lundquist Revocable Trust
Common Stock Acquisiton 2011-11-16 27,609 $0.00 72,630 No 4 C Indirect By David J. Lundquist Revocable Trust
Common Stock Acquisiton 2011-11-16 15,000 $7.00 87,630 No 4 P Indirect By David J. Lundquist Revocable Trust
Common Stock Disposition 2011-11-18 87,630 $0.00 0 No 5 G Indirect By David J. Lundquist Revocable Trust
Common Stock Acquisiton 2011-11-18 43,815 $0.00 43,815 No 5 G Indirect By David J. Lundquist 2011 Exempt Trust
Common Stock Acquisiton 2011-11-18 43,815 $0.00 43,815 No 5 G Indirect By David J. Lundquist 2011 Nonexempt Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By David J. Lundquist Revocable Trust
No 4 C Indirect By David J. Lundquist Revocable Trust
No 4 C Indirect By David J. Lundquist Revocable Trust
No 4 C Indirect By David J. Lundquist Revocable Trust
No 4 P Indirect By David J. Lundquist Revocable Trust
No 5 G Indirect By David J. Lundquist Revocable Trust
No 5 G Indirect By David J. Lundquist 2011 Exempt Trust
No 5 G Indirect By David J. Lundquist 2011 Nonexempt Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series AA Preferred Stock Disposition 2011-11-16 27,780 $0.00 27,780 $0.00
Common Stock Series B Preferred Stock Disposition 2011-11-16 19,999 $0.00 19,999 $0.00
Common Stock Series C Preferred Stock Disposition 2011-11-16 20,000 $0.00 20,000 $0.00
Common Stock Series E Preferred Stock Disposition 2011-11-16 5,257 $0.00 5,257 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Every one share of Series AA Preferred Stock automatically converted into approximately 0.476 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date. Includes 39 shares acquired by dividend issued upon conversion of Series AA Preferred Stock.
  2. Every one share of Series B Preferred Stock automatically converted into approximately 0.476 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date.
  3. Every one share of Series C Preferred Stock automatically converted into approximately 0.542 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date.
  4. Every one share of Series E Preferred Stock automatically converted into approximately 5.252 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date.
  5. The shares were purchased in the Issuer's initial public offering.